Marion Jurk

Marion Jurk possesses extensive experience in the biopharmaceutical industry, currently serving as the Executive Director of Preclinical Development at T-knife Therapeutics since November 2021. Previously, Marion held the position of Program Manager for Cellular Therapy at Miltenyi Biotec for a decade, focusing on the development of advanced therapy medicinal products from research and development through to clinical trial applications. Additional roles include Senior Project Manager at Miltenyi Biotec, Director of Discovery & Development at Coley Pharmaceutical GmbH, and Postdoctoral Fellow at Boston University and Ludwig-Maximilians Universität München, concentrating on signal transduction, innate immunity, and cancer immunotherapy research. Educational credentials include a PhD in Biochemistry and a Diplom in Chemistry from Ludwig-Maximilians-Universität München.